278 related articles for article (PubMed ID: 35325848)
1. Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review.
Almas T; Rehman S; Mansour E; Khedro T; Alansari A; Malik J; Alshareef N; Nagarajan VR; Al-Awaid AH; Alsufyani R; Alsufyani M; Rifai A; Alzahrani A; Nagarajan DR; Abdullatif T; Gunasaegaram V; Alzadjali E; Subramanian A; Rahman A; Sattar Y; Galo J; Virk HUH; Alraies MC
Biomed Pharmacother; 2022 May; 149():112843. PubMed ID: 35325848
[TBL] [Abstract][Full Text] [Related]
2. Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?
Li YE; Wang S; Reiter RJ; Ren J
Int J Infect Dis; 2022 Nov; 124():1-10. PubMed ID: 36075372
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.
Block JP; Boehmer TK; Forrest CB; Carton TW; Lee GM; Ajani UA; Christakis DA; Cowell LG; Draper C; Ghildayal N; Harris AM; Kappelman MD; Ko JY; Mayer KH; Nagavedu K; Oster ME; Paranjape A; Puro J; Ritchey MD; Shay DK; Thacker D; Gundlapalli AV
MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(14):517-523. PubMed ID: 35389977
[TBL] [Abstract][Full Text] [Related]
4. Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.
Maeda M; Isawa T; Tada N
Circ J; 2022 Mar; 86(4):724. PubMed ID: 34866122
[No Abstract] [Full Text] [Related]
5. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Complications Associated with COVID-19, MIS-C, and mRNA COVID-19 Vaccination.
Chin SE; Bhavsar SM; Corson A; Ghersin ZJ; Kim HS
Pediatr Cardiol; 2022 Mar; 43(3):483-488. PubMed ID: 35258639
[TBL] [Abstract][Full Text] [Related]
7. The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination.
Haaf P; Kuster GM; Mueller C; Berger CT; Monney P; Burger P; Stämpfli SF; Attenhofer Jost CH; Zellweger MJ; Osswald S; Donner BC; Koestner SC; Tanner FC
Swiss Med Wkly; 2021 Oct; 151():w30087. PubMed ID: 34668687
[TBL] [Abstract][Full Text] [Related]
8. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.
Montgomery J; Ryan M; Engler R; Hoffman D; McClenathan B; Collins L; Loran D; Hrncir D; Herring K; Platzer M; Adams N; Sanou A; Cooper LT
JAMA Cardiol; 2021 Oct; 6(10):1202-1206. PubMed ID: 34185045
[TBL] [Abstract][Full Text] [Related]
9. [Facing COVID-19 : myocarditis following vaccination with mRNA SARS-CoV-2].
Weerts V; Lempereur M; Léonard P; Lancellotti P
Rev Med Liege; 2023 Mar; 78(3):141-146. PubMed ID: 36924151
[TBL] [Abstract][Full Text] [Related]
10. COVID Vaccine-Associated Uveitis.
Habot-Wilner Z; Neri P; Okada AA; Agrawal R; Xin Le N; Cohen S; Fischer N; Kilmartin F; Coman A; Kilmartin D
Ocul Immunol Inflamm; 2023 Aug; 31(6):1198-1205. PubMed ID: 37145198
[TBL] [Abstract][Full Text] [Related]
11. New-Onset Acute Interstitial Nephritis Post-SARS-CoV-2 Infection and COVID-19 Vaccination: A Panoramic Review.
Wang Y; Yang L; Xu G
J Epidemiol Glob Health; 2023 Dec; 13(4):615-636. PubMed ID: 37870719
[TBL] [Abstract][Full Text] [Related]
12. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A
Front Immunol; 2022; 13():956825. PubMed ID: 36177033
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents.
Karlstad Ø; Hovi P; Husby A; Härkänen T; Selmer RM; Pihlström N; Hansen JV; Nohynek H; Gunnes N; Sundström A; Wohlfahrt J; Nieminen TA; Grünewald M; Gulseth HL; Hviid A; Ljung R
JAMA Cardiol; 2022 Jun; 7(6):600-612. PubMed ID: 35442390
[TBL] [Abstract][Full Text] [Related]
14. Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older.
Simone A; Herald J; Chen A; Gulati N; Shen AY; Lewin B; Lee MS
JAMA Intern Med; 2021 Dec; 181(12):1668-1670. PubMed ID: 34605853
[TBL] [Abstract][Full Text] [Related]
15. [Myocarditis and pericarditis following mRNA COVID-19 vaccination. Expert opinion of the Italian Society of Cardiology].
Sinagra G; Porcari A; Merlo M; Barillà F; Basso C; Ciccone MM; Curcio A; Mancone M; Mercuro G; Muscoli S; Nodari S; Pedrinelli R; Spaccarotella C; Filardi PP; Indolfi C
G Ital Cardiol (Rome); 2021 Nov; 22(11):894-899. PubMed ID: 34709228
[TBL] [Abstract][Full Text] [Related]
16. Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series.
Fazlollahi A; Zahmatyar M; Noori M; Nejadghaderi SA; Sullman MJM; Shekarriz-Foumani R; Kolahi AA; Singh K; Safiri S
Rev Med Virol; 2022 Jul; 32(4):e2318. PubMed ID: 34921468
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccinations: The unknowns, challenges, and hopes.
Mohamed K; Rzymski P; Islam MS; Makuku R; Mushtaq A; Khan A; Ivanovska M; Makka SA; Hashem F; Marquez L; Cseprekal O; Filgueiras IS; Fonseca DLM; Mickael E; Ling I; Arero AG; Cuschieri S; Minakova K; Rodríguez-Román E; Abarikwu SO; Faten AB; Grancini G; Cabral-Marques O; Rezaei N
J Med Virol; 2022 Apr; 94(4):1336-1349. PubMed ID: 34845731
[TBL] [Abstract][Full Text] [Related]
18. Incidence and management of the main serious adverse events reported after COVID-19 vaccination.
Padilla-Flores T; Sampieri A; Vaca L
Pharmacol Res Perspect; 2024 Jun; 12(3):e1224. PubMed ID: 38864106
[TBL] [Abstract][Full Text] [Related]
19. Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents.
Chelala L; Jeudy J; Hossain R; Rosenthal G; Pietris N; White CS
AJR Am J Roentgenol; 2022 Apr; 218(4):651-657. PubMed ID: 34704459
[No Abstract] [Full Text] [Related]
20. Vaccine Side Effects Following COVID-19 Vaccination Among the Residents of the UAE-An Observational Study.
Ganesan S; Al Ketbi LMB; Al Kaabi N; Al Mansoori M; Al Maskari NN; Al Shamsi MS; Alderei AS; El Eissaee HN; Al Ketbi RM; Al Shamsi NS; Saleh KM; Al Blooshi AF; Cantarutti FM; Warren K; Ahamed F; Zaher W
Front Public Health; 2022; 10():876336. PubMed ID: 35602146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
